You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,747,019


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,747,019
Title: Low dose estrogen interrupted hormone replacement therapy
Abstract:A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17.beta.-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17.beta.-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 .mu.g per day of norgestimate.
Inventor(s): Casper; Robert F. (Toronto, CA), Shangold; Gary A. (Califon, NJ), Ausmanas; Militza K. (Lake Forest, IL)
Assignee: Jencap Research, Ltd. (Toronto, CA) Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:10/134,455
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 6,747,019

Introduction

When navigating the complex world of patent law, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 6,747,019, using it as a case study to illustrate key concepts in patent drafting, prosecution, and the broader patent landscape.

What is a Patent?

A patent is a legal document granted by the U.S. government that gives the inventor exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[2].

Elements of a Patent Application

A utility patent application, like the one for U.S. Patent 6,747,019, includes several critical elements:

  • Title: A brief description of the invention.
  • Abstract: A concise summary of the invention.
  • Drawings: Visual representations of the invention.
  • Background of the Invention: Context and prior art related to the invention.
  • Brief Summary of the Invention: An overview of the invention.
  • Description of the Drawings: Detailed explanations of the drawings.
  • Detailed Description of the Invention: A comprehensive explanation of how the invention works.
  • Claims: The legal definitions of the invention that define the scope of protection[1].

The Importance of Specifications and Claims

In drafting a patent application, both the specification and the claims are vital. The specification explains how the invention works and provides context, while the claims define the boundaries of the patent protection. The specification can rarely be changed during prosecution, making it crucial to get it right from the start[2].

Specifications

The specification must be detailed enough to enable a person skilled in the relevant art to make and use the invention. It should include exemplary embodiments and specific structures, materials, or acts to support the claims. For example, in Aristocrat Technologies, Inc. v. International Game Technology, the Federal Circuit held that merely stating a standard microprocessor without disclosing specific algorithms was insufficient[2].

Claims

Claims are the heart of a patent application and define the scope of protection. They can be amended during prosecution to redefine this scope. However, any amendments must be supported by the original specification. The case of Kustom Signals, Inc. v. Applied Concepts, Inc. highlights the importance of careful claim drafting to avoid unintended limitations[2].

Analyzing U.S. Patent 6,747,019

To analyze U.S. Patent 6,747,019, one would need to review its specific elements:

Title and Abstract

The title and abstract provide a preliminary understanding of the invention. For instance, if the patent is related to a technological innovation, these sections would outline the key features and benefits.

Background and Summary

The background and summary sections offer context on the prior art and the problems the invention solves. This helps in understanding the novelty and non-obviousness of the invention.

Drawings and Description

The drawings and their descriptions are critical for visualizing the invention. These must be clear and detailed to support the claims.

Detailed Description

This section provides a comprehensive explanation of the invention, including how it works and any variations or embodiments.

Claims

The claims section is where the legal boundaries of the patent are defined. Each claim must be supported by the specification and must be clear, concise, and definite.

Patent Prosecution Process

The prosecution process involves the interaction between the patent applicant and the U.S. Patent and Trademark Office (USPTO). Here are some key aspects:

Timeline

The timeline for patent examination varies by subject matter. For example, patents in the category of Computer Architecture, Software, and Information Security can take almost 21 months to receive the first office action, while Mechanical Engineering, Manufacturing, and Products can take around 30 months[1].

Expedited Examination

Expedited examination options, such as Accelerated Examination and Track One Prioritized Examination, can reduce the examination time to 12 months. However, these options come with additional requirements and fees[1].

Patent Landscape and Trends

Understanding the broader patent landscape is essential for strategic patenting.

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014. This dataset helps in analyzing trends and scope measurements in patent claims[3].

International Harmonization

Efforts like the Common Citation Document (CCD) aim to harmonize patent systems globally, making it easier to search and compare prior art across different patent offices[4].

Practical Considerations and Strategies

When drafting and prosecuting a patent application, several practical considerations and strategies are important:

Retaining Qualified Counsel

Given the complexity of U.S. patent law, it is advisable to retain qualified U.S. counsel to guide the application through the prosecution process[2].

Do's and Don'ts

Following a list of "do's and don'ts" can help in drafting strong and broad patent claims. For example, disclosing specific structures and materials in the specification is crucial[2].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. This could provide a more accessible and efficient way to resolve patent disputes for smaller entities[5].

Key Takeaways

  • Detailed Specifications: The specification is as important as the claims and must be detailed enough to enable a person skilled in the art to make and use the invention.
  • Careful Claim Drafting: Claims define the scope of protection and must be carefully drafted to avoid unintended limitations.
  • Expedited Examination: Options like Track One Prioritized Examination can significantly reduce the examination time.
  • Patent Landscape: Understanding trends and scope measurements in patent claims is crucial for strategic patenting.
  • Qualified Counsel: Retaining qualified U.S. counsel can significantly improve the chances of successful patent prosecution.

FAQs

What are the key elements of a utility patent application?

The key elements include the Title, Abstract, Drawings, Background of the invention, Brief summary of the invention, Description of the Drawings, detailed description of the invention, and Claims.

How long does the patent examination process typically take?

The timeline varies by subject matter, but it can range from 18 months for design patents to over 30 months for certain technology areas.

What is the difference between Accelerated Examination and Track One Prioritized Examination?

Accelerated Examination requires an extensive prior art search and a petition, while Track One Prioritized Examination has no special requirements but carries a higher fee.

Why is the specification important in a patent application?

The specification is crucial because it provides the context and detailed explanation of the invention, which cannot be changed during prosecution.

What is the purpose of the Common Citation Document (CCD)?

The CCD provides a single point of access to prior art cited by multiple patent offices, facilitating a more integrated global patent system.

Sources

  1. TIMELINE AND COSTS FOR PATENT FILINGS - SBIR
  2. Practical Considerations and Strategies in Drafting U.S. Patent - Finnegan
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,747,019

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,747,019

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 029159 ⤷  Subscribe
Australia 3412300 ⤷  Subscribe
Brazil 0010968 ⤷  Subscribe
Canada 2267743 ⤷  Subscribe
China 1200747 ⤷  Subscribe
China 1358104 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.